Pure Global
NCT05658913

Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)

University of Pennsylvania·ClinicalTrials.gov·drugRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Alzheimer's Disease
Drug/Device/Intervention
AV-1451
Study type
Observational
Intervention type
drug
Sponsor & location
Primary sponsor
University of Pennsylvania
Location
Philadelphia, United States of America
Timeline & enrollment
Phase
N/A
Start date
Mar 15, 2023
End date
Dec 01, 2029
Enrollment
50 participants
Primary outcome

Clusters based on spatial pattern and extent of T-N Mismatch

Summary

To collect Tau PET/CT imaging in older adults diagnosed with Mild Cognitive Impairment (MCI)
 or Alzheimer's Disease (AD) in the Mismatch Prospective Cohort Study (MPC-Tau) study to
 determine relationship to clinical, cognitive, and other biomarker data. Findings from this
 study will likely provide insight into the phenotypic variability of Alzheimer's Disease and
 other related pathologies.

ICD-10 classifications
Alzheimer diseaseAlzheimer disease, unspecifiedOther Alzheimer diseaseDementia in Alzheimer diseaseDementia in Alzheimer disease, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05658913
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05658913 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Pennsylvania and is currently Recruiting. The study focuses on Alzheimer's Disease. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.